RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RXST is expected to report earnings to rise 163.27% to -28 cents per share on November 11
Q3'26
Est.
$-0.29
Q2'26
Beat
by $0.25
Q1'26
Beat
by $0.12
Q4'25
Beat
by $0.32
Q3'25
Beat
by $0.34
The last earnings report on August 05 showed earnings per share of -10 cents, beating the estimate of -36 cents. With 1.10M shares outstanding, the current market capitalization sits at 259.96M.